ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zweep, H. P.
Right arrow Articles by Wildevuur, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zweep, H. P.
Right arrow Articles by Wildevuur, C. R.

The Annals of Thoracic Surgery, Vol 55, 427-433, Copyright © 1993 by The Society of Thoracic Surgeons


ARTICLES

Autologous vein supported with a biodegradable prosthesis for arterial grafting

HP Zweep, S Satoh, B van der Lei, WL Hinrichs, F Dijk, J Feijen and CR Wildevuur
Cardiopulmonary Surgery Research Division, University Hospital Groningen, The Netherlands.

To evaluate the potential of a supporting, compliant, biodegradable prosthesis to function as a temporary protective scaffold for autologous vein grafts in the arterial circulation, we implanted vein grafts into the carotid arteries of rabbits, either with (composite grafts) or without (control grafts) such a supporting prosthesis, and evaluated them up to 6 weeks. The control vein grafts showed edema and severe medial disruption with infiltration of polymorphonuclear cells on day 1. Over the study, irregular fibrocyte formation resulted in the formation of a fibrotic vein wall. In contrast, the composite vein grafts showed preservation of smooth muscle cell layers and elastic laminae with a minor inflammatory response. Regular proliferation of fibroblasts, which in some areas were circularly oriented, was observed. We conclude that a supporting, compliant, biodegradable prosthesis can function as a protective scaffold for vein grafts in the arterial circulation, thus reducing damage to the vein graft wall and allowing gradual arterialization.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Zilla, P. Human, M. Wolf, W. Lichtenberg, N. Rafiee, D. Bezuidenhout, N. Samodien, C. Schmidt, and T. Franz
Constrictive external nitinol meshes inhibit vein graft intimal hyperplasia in nonhuman primates
J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 717 - 725.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Y. Jeremy, R. Bulbulia, J. L. Johnson, P. Gadsdon, V. Vijayan, N. Shukla, F. C. T. Smith, and G. D. Angelini
A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening
J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1766 - 1772.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. Stooker, M. Gok, P. Sipkema, H. W. M. Niessen, A. Baidoshvili, N. Westerhof, E. K. Jansen, C. R. H. Wildevuur, and L. Eijsman
Pressure-diameter relationship in the human greater saphenous vein
Ann. Thorac. Surg., November 1, 2003; 76(5): 1533 - 1538.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
W. Stooker, H.W.M. Niessen, W.R. Wildevuur, V.W.M. van Hinsbergh, J. Fritz, E.K. Jansen, Ch.R.H. Wildevuur, and L. Eijsman
Perivenous application of fibrin glue reduces early injury to the human saphenous vein graft wall in an ex vivo model
Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 212 - 217.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. Stooker, H. W. M. Niessen, A. Baidoshvili, W. R. Wildevuur, V. W. M. Van Hinsbergh, J. Fritz, C. R. H. Wildevuur, and L. Eijsman
Perivenous support reduces early changes in human vein grafts: Studies in whole blood perfused human vein segments
J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0290 - 297.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. R. Zurbrugg, F. Knollmann, M. Musci, M. Wied, M. Bauer, T. Chavez, A. Krukenberg, and R. Hetzer
The biocompound method in coronary artery bypass operations: surgical technique and 3-year patency
Ann. Thorac. Surg., November 1, 2000; 70(5): 1536 - 1540.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. Brauner, H. Laks, D. C. Drinkwater Jr., G. Chaudhuri, O. Shvarts, T. Drake, S. Bhuta, D. Mishaly, I. Fishbein, and G. Golomb
CONTROLLED PERIADVENTITIAL ADMINISTRATION OF VERAPAMIL INHIBITS NEOINTIMAL SMOOTH MUSCLE CELL PROLIFERATION AND AMELIORATES VASOMOTOR ABNORMALITIES IN EXPERIMENTAL VEIN BYPASS GRAFTS
J. Thorac. Cardiovasc. Surg., July 1, 1997; 114(1): 53 - 63.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1993 by The Society of Thoracic Surgeons.